Resources

Type of publications
Regions
Diseases

5255 results found

2022 ∙ Dadras, O. SeyedAlinaghi, S. Karimi, A. Shamsabadi, A. Mahdiabadi, S. Mohammadi, P. Amiri, A. Shojaei, A. Pashaei, Z. Mirzapour, P. Qaderi, K. MohsseniPour, M. Alilou, S. Mehraeen, E. Jahanfar, S.

Public acceptability of COVID-19 vaccines and its predictors in Middle ‎Eastern/North African (MENA) countries: a systematic review‎

  • Africa
  • All age groups
  • Healthcare workers
  • Low and Middle Income Countries
  • COVID-19
  • Acceptance
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Ngangue, P. Pilabré, A. H. Barro, A. Pafadnam, Y. Bationo, N. Soubeiga, D.

Public attitudes towards COVID-19 vaccines in Africa: A systematic review

  • Africa
  • Adults
  • Healthcare workers
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Mannocci, A. Pellacchia, A. Millevolte, R. Chiavarini, M. de Waure, C.

Quadrivalent Vaccines for the Immunization of Adults against Influenza: A Systematic Review of Randomized Controlled Trials

  • Adults
  • Influenza
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Ng, S. M. Pan, J. Mouyis, K. Kondapally Seshasai, S. R. Kapil, V. Rice, K. M. Gupta, A. K.

Quantifying the Excess Risk of Adverse COVID-19 Outcomes in Unvaccinated Individuals With Diabetes Mellitus, Hypertension, Ischaemic Heart Disease or Myocardial Injury: A Meta-Analysis

  • Adults
  • Low and Middle Income Countries
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Low
2022 ∙ Oueijan, R. I. Hill, O. R. Ahiawodzi, P. D. Fasinu, P. S. Thompson, D. K.

Rare Heterogeneous Adverse Events Associated with mRNA-Based COVID-19 Vaccines: A Systematic Review

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Nguyen, T. T. Quach, T. H. T. Tran, T. M. Phuoc, H. N. Nguyen, H. T. Vo, T. K. Vo, G. V.

Reactogenicity and immunogenicity of heterologous prime-boost immunization with COVID-19 vaccine

  • Adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Wang, K. Wang, L. Li, M. Xie, B. He, L. Wang, M. Zhang, R. Hou, N. Zhang, Y. Jia, F.

Real-Word Effectiveness of Global COVID-19 Vaccines Against SARS-CoV-2 Variants: A Systematic Review and Meta-Analysis

  • All age groups
  • COVID-19
  • Administration
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Wang, W. Kothari, S. Baay, M. Garland, S. M. Giuliano, A. R. Nygard, M. Velicer, C. Tota, J. Sinha, A. Skufca, J. Verstraeten, T. Sundstrom, K.

Real-world impact and effectiveness assessment of the quadrivalent HPV vaccine: a systematic review of study designs and data sources

  • All age groups
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Wang, W. V. Kothari, S. Skufca, J. Giuliano, A. R. Sundstrom, K. Nygard, M. Koro, C. Baay, M. Verstraeten, T. Luxembourg, A. Saah, A. J. Garland, S. M.

Real-world impact and effectiveness of the quadrivalent HPV vaccine: an updated systematic literature review

  • All age groups
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Bencina, G. Costantino, C. Mameli, C. Sabale, U. Murtagh, J. Newman, R. Ahern, A. Bhaila, R. Sanchez, A. O. Martinon-Torres, F. Carias, C.

Real-world impact of rotavirus vaccination in European healthcare settings: a systematic literature review

  • Europe
  • All age groups
  • Rotavirus
  • Coverage
  • Economic aspects
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...